Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mesothelioma × Sorafenib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Hepatocellular 62 Carcinoma, Renal Cell 35 Liver Neoplasms 17 Carcinoma, Non-Small-Cell Lung 15 Breast Neoplasms 14 Neoplasms 13 Neoplasm Metastasis 13 Melanoma 12 Leukemia, Myeloid, Acute 10 Sarcoma 9 Thyroid Neoplasms 8 Lung Neoplasms 8 Kidney Neoplasms 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 6 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Glioblastoma 4 Carcinoma, Medullary 4 Breast Neoplasms, Male 4 Brain Neoplasms 4 Thyroid Diseases 3 Thyroid Carcinoma, Anaplastic 3 Stomach Neoplasms 3 Recurrence 3 Osteosarcoma 3 Myelodysplastic Syndromes 3 Leiomyosarcoma 3 Hemangiosarcoma 3

Interventions

Pemetrexed 10 Gemcitabine 8 Cisplatin 8 Nivolumab 4 Carboplatin 4 niraparib 3 durvalumab 3 Vinorelbine 3 Ipilimumab 3 Bevacizumab 3 tremelimumab 2 pembrolizumab 2 olaparib 2 anetumab ravtansine 2 Radiotherapy, Intensity-Modulated 2 Imatinib Mesylate 2 Fluorodeoxyglucose F18 2 vandetanib 1 tazemetostat 1 sargramostim 1 ribociclib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 defactinib 1 decitabine and cedazuridine drug combination 1 bintrafusp alfa protein, human 1 Zoledronic Acid 1 Vitamin B 12 1 Valproic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00794859 2009-08-04

SMS

King's College London

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡